Experts Discuss Clinical Application of TRK Inhibitors and Tumor Agnostic NTRK Fusion Testing

Download All
In this online educational program, learn how to optimize oncology patient care by leveraging tumor-agnostic NTRK fusion testing and TRK inhibitors. Review expert insights on the latest data with an on-demand Webcast and downloadable slides from the live CCO symposium in Chicago.
Todd M. Bauer, MD
Marcia Brose, MD, PhD
George D. Demetri, MD

Downloadable Slidesets

In this downloadable slideset, George D. Demetri, MD, provides an overview on the biology of NTRK fusions in patients with cancer and the rationale for using TRK inhibitors in clinical practice.

George D. Demetri, MD Released: June 4, 2019

In this downloadable slideset, Todd M. Bauer, MD, shows the current clinical data on TRK inhibitors and how to use these agents to treat patients with NTRK fusion—positive cancer.

Todd M. Bauer, MD Released: June 4, 2019

In this downloadable slideset, Marcia S. Brose, MD, PhD, discusses her perspective and current data on optimal testing approaches for NTRK fusions in patients with cancer.

Marcia Brose, MD, PhD Released: June 4, 2019

On-Demand Webcast

Watch this on-demand Webcast from our live symposium to review the latest clinical data and expert perspectives on targeting TRK in solid tumors, available and emerging TRK inhibitors, and implementing NTRK fusion testing in practice.

Todd M. Bauer, MD Marcia Brose, MD, PhD George D. Demetri, MD Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: July 15, 2019 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Bayer HealthCare Pharmaceuticals Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue